Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00155337

Enrollment

Registered

2005-09-12

Start date

2004-08-31

Completion date

2007-12-31

Last updated

2012-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Leukoplakia

Keywords

leukoplakia, erythroleukoplakia, photodynamic therapy

Brief summary

Photodynamic therapy for oral leukoplakia and erythroleukoplakia

Detailed description

Photodynamic therapy for oral leukoplakia and erythroleukoplakia

Interventions

PROCEDUREphotodynamic therapy

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

20 Years to 80 Years

Healthy volunteers

Inclusion criteria

* patients with leukoplakia or erythroleukoplakia

Exclusion criteria

* oral cancers

Design outcomes

Primary

Measure	Time frame
End of 8 treatments	—

Secondary

Measure	Time frame
Regression of lesions	—

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026